➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Colorcon
Baxter
Dow
McKinsey
Express Scripts

Last Updated: July 8, 2020

DrugPatentWatch Database Preview

Litigation Details for ELI LILLY AND COMPANY v. ACCORD HEALTHCARE INC., USA (S.D. Ind. 2014)


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in ELI LILLY AND COMPANY v. ACCORD HEALTHCARE INC., USA
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for ELI LILLY AND COMPANY v. ACCORD HEALTHCARE INC., USA (S.D. Ind. 2014)

Date Filed Document No. Description Snippet Link To Document
2014-03-12 1 and legally issued United States Patent No. 8,404,703 (“the ’703 patent”), entitled “Medicinal Compositions… and Ube’s United States Patent No. 5,288,726 by Mylan and Nos. 8,404,703 and 8,569,325 by all Defendants… COUNT I: INFRINGEMENT BY ACCORD OF U.S. PATENT NO. 8,404,703 139. Accord USA’s filing of…ACCORD OF U.S. PATENT NO. 8,404,703 145. This count arises under… COUNT V: INFRINGEMENT BY AMNEAL OF U.S. PATENT NO. 8,404,703 173. The filing by Amneal Pharmaceuticals External link to document
2014-05-06 155 Attachments: # 1 Exhibit A (U.S. Patent No. 8,404,703), # 2 Exhibit B (U.S. Patent No. 8.569,325))(Zweig, Sally…12 March 2014 1:14-cv-00389-LJM-TAB Patent None District Court, S.D. Indiana External link to document
2014-07-18 232 IV certifications as to U.S. Patent Nos. 8,404,703 and 8,569,325 patents to paragraph III certifications…12 March 2014 1:14-cv-00389-LJM-TAB Patent None District Court, S.D. Indiana External link to document
2015-03-12 304 on the label (U.S. Patent No. 8,404,703 and 8,569,325 (the ‘703 and ‘325 patents)). The Mylan…active ingredient in Effient® (U.S. Patent No. 5,288,726 (the ‘726 patent)), and methods of using Effient®…that Defendants infringed three of Plaintiffs’ patents by filing an Abbreviated New Drug Application …acute coronary syndrome who receive stents. The patents at issue protect the molecule prasugrel hydrochloride…defendants who challenged the validity of Plaintiffs’ patents that cover Effient®.2 Defendant Mylan, Inc. (“Mylan External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson
Harvard Business School
AstraZeneca
McKesson
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.